跳至主要内容
临床试验/NCT05645419
NCT05645419尚未招募不适用

Development of Chronoprognosis of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus and Development of Personalized Chronoprevention

University Medical Center, Kazakhstan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Number of Participants with myocardial infarction

研究概览

简要总结

Purpose: To develop a mathematical model for the occurrence of MI in patients with T2D by studying the relationship between the internal personalized biorhythms of the patients and the external transit rhythms of space objects; to develop and implement a personalized method of chrono-prevention of MI in patients with T2D.

Obejectives:

1.1 To investigate patterns of the influence of external transit rhythms of space objects on the occurrence of MI in patients with T2D: an observational study using clinical databases.

1.2 To investigate patterns of influence of cyclic activity of helio- and geophysical phenomena in the interplanetary medium on the occurrence of MI in patients with T2D.

  1. Develop a mathematical model for predicting the occurrence of MI in patients with T2D, based on the identification of the relationship patterns between the internal personalized biorhythms of these patients and the external transit rhythms of space objects.

  2. To investigate the effectiveness of the mathematical model for predicting the occurrence of MI in patients with T2D for the purpose of personalized chrono-prevention: a randomized clinical trial.

详细描述

Participants and study design.

  1. Study of the influence of external transit rhythms of space objects, as well as the cyclic activity of helio- and geophysical phenomena in the interplanetary medium on the occurrence of MI in patients with T2D combining population based and clinical data.

For a retrospective population study, all patients aged 30-65 years with T2D (MI+/-) from the republican database of the Ministry of Health of the Republic of Kazakhstan (MoH) over the past 10 years will be included.

For a prospective population trial ≥150 patients aged 30-65 years with T2D (MI+/-) will be included. 2. Mathematical and statistical analysis of the collected chrono-geo-biological and clinical data and data on the relationship between the internal personalized biorhythms of the patients and the external transit rhythms of space objects with the definition of "critical periods" as well as the cyclic activity of helio- and geophysical phenomena in the interplanetary medium. Study duration: 12-24 weeks. 3. Study of the effectiveness of the developed mathematical model for predicting the occurrence of MI in patients with T2D in a pilot prospective randomized clinical trial (personalized chronoprophylaxis). The study will include at least 60 patients aged 30-65 years of both sexes with moderate T2D: 1) the main group (n≥30), where patients with T2D will additionally receive personalized chronoprevention intervention; 2) the control group (n≥30), where patients with T2D will only be under observation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients aged 30-65 years of both sexes
  • •severe-to-moderate subcompensated stage of T2D without MI
  • •decompensated stage of T2D without MI

排除标准

  • •compensated stage of T2D without MI
  • •patients with T2D and with MI

研究组 & 干预措施

personalized chronoprevention

Experimental

the main group (n=30), where patients with T2D, in addition to their traditional prescriptions, will receive the intervention method of personalized chronoprevention

干预措施: personalized chronoprevention (Behavioral)

traditional prescriptions

No Intervention

the control group (n=30), where patients with T2D will only be under observation in addition to their traditional prescriptions

结局指标

主要结局

Number of Participants with myocardial infarction

时间窗: 24 weeks

occurence of myocardial infarction

次要结局

未报告次要终点

研究者

发起方
University Medical Center, Kazakhstan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kuat Oshakbayev

a principal investigator

University Medical Center, Kazakhstan

研究点 (1)

Loading locations...

相似试验